Plain-English translation of NCT06752928 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares two ways of monitoring your blood sugar while you're in the hospital with type 1 diabetes. One group will use the standard finger-stick testing (the way many hospitals currently check blood sugar), while the other group will wear a Dexcom G7 continuous glucose monitor—a small sensor that tracks your blood sugar levels throughout the day. Researchers want to find out which method helps doctors manage your insulin better and keep your blood sugar in a safer range.
People with type 1 diabetes are hospitalized more often and stay longer than others, and their blood sugar is often harder to control while in the hospital. This treatment can show your blood sugar trends continuously, but no one has studied whether it actually helps hospitalized type 1 diabetes patients better than the standard testing method.
You likely qualify if…
You likely don't qualify if…
After your severe high blood sugar is brought under control, you would be randomly assigned to either the standard blood sugar testing group or the Dexcom monitor group. If assigned to the standard group, you'll have finger-stick blood sugar checks before meals and bedtime, and your doctors will adjust your insulin based on those results. If assigned to the Dexcom group, you'll wear the continuous monitor during your hospital stay (up to 10 days), and your doctors will use those readings to guide your insulin. In both groups, you'll also wear a hidden monitor that collects extra data for the research team, though you won't see its readings.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States